Target intelligence / Profile preview

Sp5 transcription factor (SP5)

Target
SP5
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

The Sp5 transcription factor (SP5) is a member of the Sp family of zinc finger transcription factors. It acts as a DNA-binding transcription factor, regulating transcription via RNA polymerase II and cis-regulatory region binding. SP5 is a direct WNT target gene and acts as a crucial modulator of WNT/β-catenin signaling, especially in controlling gene expression duration in developmental contexts, such as in stem cells. It is essential for the formation of primary and motile cilia across cell types, acting at the top of the transcriptional network that drives cilia gene expression. Elevated SP5 expression is associated with a variety of cancers, where it promotes tumor cell growth, migration, and metastasis, in part by regulating other oncogenic pathways. SP5's dysfunction is implicated both in cancer biology and ciliopathies—developmental disorders arising from abnormal cilia formation and function. Note: - There is no evidence SP5 is a direct target for any approved therapeutics, nor are there listed interacting drugs or defined mechanisms of action for drug targeting. - SP5's roles in cancer and cilia-associated disease make it a potential research or diagnostic biomarker, but not a direct therapeutic target at this time.

Other names
Transcription factor Sp5SP5Sp5SP5_HUMAN
02

Biological functions

Regulation of transcription by RNA polymerase IIRegulation of gene expressionCilia formation (primary and motile cilia)Inhibition/termination of WNT/β-catenin signaling responsesEarly neural crest induction (downstream of WNT and FGF pathways)Regulation of developmental processes, including bone morphogenesis and cellular responses to organic cyclic compounds
03

Disease associations

Cancer (colorectal cancer metastasis, tumor progression, prostate cancer)Ciliopathies (defects in cilia formation, potentially leading to developmental disorders)
04

Safety considerations

Potential role in oncogenesis and tumor progression due to overexpression or gain-of-functionPossible developmental abnormalities and ciliopathies from SP5 dysfunction
05

Biomarkers

SP5 expression may serve as a biomarker in certain cancers (e.g., colorectal, prostate)

Beyond the preview

Go deeper on Sp5 transcription factor (SP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sp5 transcription factor (SP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call